Goodmans IP Litigation Team Wins Again at LMG Life Sciences Americas Awards 2025

We are proud to share Goodmans LLP has been recognized at the LMG Life Sciences Americas Awards 2025 for the second consecutive year!

Goodmans IP Group Wins Patent Impact Case of the Year Again for Takeda Canada v Apotex

Congratulations to the Goodmans Intellectual Property Litigation Team, who won a Patent Impact Case of the Year award for their representation of Apotex Inc., in which they successfully avoided a finding of patent infringement sought by Takeda relating to dexlansoprazole products. This is the team's second impact case of the year award in 2025.

The Goodmans trial team consisted of Andrew Brodkin, Jenene Roberts, Jaclyn Tilak, Jerry Topolski and Emily Groper.  Congratulations to all!

About Goodmans IP Litigation Group

Goodmans is the “best patent litigation firm in Canada” (Chambers Canada) and “… the number one firm in Canada by far…simply put, there is Goodmans and then there is the rest” (IAM Patent 1000). Industry leaders repeatedly turn to Goodmans when the need arises to assert their intellectual property rights, whether it be patents, trademarks or copyright or to defend against claims of patent, trademark or copyright infringement. Our Goodmans IP litigation bench is deep, with industry-recognized lawyers and leaders of the future working alongside several in-house PhD-level scientists.

To learn more about the Goodmans IP Group, click here.

---

About LMG Life Sciences Americas Awards

The LMG Life Sciences Americas Awards recognize the region’s most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months. After months of research and submission reviews, the LMG Life Sciences team set out to uncover the most impactful cases, deals, and the lawyers and law firms behind them.

For more information, visit the LMG Life Sciences website.